FGF21 and type 2 diabetes mellitus: Collectively, these findings underscore the dual potential of FGF21 as a biomarker of metabolic stress and a therapeutic target, offering opportunities to simultaneously improve systemic metabolism and cognitive health in OB and T2DM.